10000 to 4crs in 18 months 1000rs to 50crs 300% returns 75% promoter holdings A 50 bagger A sureshot 5 bagger Analysis Another fraud? Auto ancillaries Bank sector Blind sell Brand plays Broking Bse Nse Buy calls cements Ceramics/tiles Counters I don't like Debt free businesses Delisting candidates demerger bets Disclosure- I own them Domestic consumption plays E-Commerce pick Education Exit at rallies Famous analysts Famous stocks FMCG Footwear future multibaggers Gems andJewellery Hidden gems High conviction ideas High dividend plays High potential small caps High ROE stocks Holding companies Hotel sector How they looted you.. Indian stock market Infrastructure sector Interesting Microcaps IT KPO Landbank plays largecap ideas Less than 5 PE stocks Liquor Logistics Market lessons Market outlook for 2013 and 2014 Market underperformers Meeting with the CEO Metals Monopoly businesses My 5 baggers My Favourite counters My paid stock recommendations My stock picking techniques nse bse tips Oil exploration Operator calls Paints Penny stock outlook penny stock updates Pharma sector Poultry stocks PSU Publicity freaks Real estate Renewable energy plays Safe bets Sell recommendations Share market Live shipping stocks short term call SOTP plays stock tips stock under 10rs Stocks to watch out for Strong bonus candidates Takeover candidates TATA product tea Textiles The 13 bagger The 45 bagger Trading companies Transformers Turnaround bets Tyres Uncertain/Risky business models Unique businesses

Search This Blog(Over 800 companies covered in the blog).

Archives : Old artciles

Thursday, August 23, 2012

Kilpest India Ltd:Buy/sell/growth prospect and recommendation,news and results,target and analysis,view and outlook,multibagger

Scripscan:Kilpest India Ltd

Story:Kilpest India Ltdis an established 40-year old Agri-input company,manufacturing & selling a range of crop-protection products like pesticides (including bio-pesticides), micro-nutrients & bio-fertilizers.The company has a product portfolio of about 50 different products which it sells through a nationwide distribution network of over 2000 dealers. The "Kilpest" brand is well established in the north, particularly Madhya Pradesh, and in some areas it is even used generically by farmers when they wish to ask for pesticides in general.In 2010, Kilpest identified molecular diagnostics as a future growth-driver, and tied up with a leading Spanish Biotechnology company M/S Biotools B&M Labs S.A - focussed on molecular biology & diagnostics - and it's spin-off company 2B Blackbio S.L - a biotech company focused on Personalized medicine, nutrigenomics , pharmacogenomics & companion diagnostics - to form a new joint venture company 3B Blackbio Biotech India Ltd.3B Blackbio Biotech India Ltd intends to lead the research and development of new tools in the field of personalized medicine, medical diagnostics, pharmacogenomics, as well as provide diagnostic tests to predict drug treatment effectiveness (Companion Diagnostics) and enter the field of nutrigenomics.Kilpest India thanks to its couple of JV's now operates in 2 exciting spaces :1)Agriculture, focusing on crop-protection protection products , both chemical-based & biological (chemical free).2) Healthcare, with special focus on molecular diagnostics , nutrigenomics & personalized medicine.The humungous potential of both these segments need not be explained. Rather, what needs to be closely watched is the company's growth plans, execution skills & also it's ability to raise the funds required to propel growth.Hitherto, the company has been rather conservative & has not chased growth aggressively, but this is expected to change going forward, with the 2nd generation of promoter management now effectively at the helm. If Kilpest India can optimally execute it's growth plans going forward, it can deliver excellent returns to it's shareholders over the medium to long term.But crucial to shareholder returns will also be how & by what route the company is able to raise the funds it requires for it's expansion, especially in the new line of business which is a high margin business. Any substantial equity dilution will dilute shareholder returns.Keeping this in mind, the author recommends investors to closely study & track this company going forward, and take an appropriate call based on their conviction in this idea, after proper study.
Source:Bosco menezes.

Important Disclaimer&Privacy policy

This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.

Subscription to Arunthestocksguru

Enter your email address:

Delivered by FeedBurner